Uterine (Endometrial) Cancer Treatment in Ahmedabad

Expert Medical Oncology Care for Uterine (Endometrial) Cancer at Every Stage

What is Uterine Cancer?

Uterine cancer, most commonly known as endometrial cancer, is a cancer that develops in the uterus, often beginning in the inner lining called the endometrium. It is one of the most frequently diagnosed gynecologic cancers, and in many women, it is detected early because abnormal uterine bleeding can be an early sign of the disease.

A diagnosis of uterine cancer can be overwhelming, bringing with it questions about the type of cancer, its stage, and what lies ahead. Understanding where the cancer has developed and its biological characteristics is an important part of evaluating the condition and making informed decisions about care.

Whether you have recently been diagnosed, have undergone surgery, require additional treatment, or wish to seek a second opinion, every cancer journey begins with a careful evaluation of your condition.

When Should You Meet a Medical Oncologist?

Many women first meet a Medical Oncologist after surgery or following a biopsy confirming uterine cancer. An early consultation helps explain the diagnosis, review pathology findings, and determine whether additional treatment will be beneficial. You should consider consulting a Medical Oncologist if:

Why Early Consultation Matters

Abnormal uterine bleeding is often the first warning sign of uterine cancer, but many women delay seeking medical attention, assuming it is related to menopause or hormonal changes. Consulting a Medical Oncologist soon after diagnosis—or when cancer is suspected—helps ensure timely staging, appropriate treatment planning, and a clear understanding of the therapies that may be recommended. Early specialist involvement also helps coordinate care with gynecologic oncology and radiation oncology teams whenever required.

Every Uterine Cancer Needs a Different Plan

The disease is most commonly diagnosed after menopause, although it can also occur in younger women. One of its earliest warning signs is abnormal uterine bleeding, which allows many women to seek medical attention before the cancer has spread beyond the uterus.

Treatment may involve surgery, chemotherapy, radiation therapy, hormone therapy, immunotherapy, targeted therapy, or a combination of these approaches. Advances in molecular testing have improved the understanding of uterine cancer, allowing treatment decisions to be guided not only by the stage of the disease but also by the biological characteristics of the tumour.

How Dr. Manasi Shah Plans Your Treatment

No two uterine cancers are exactly alike. Before recommending treatment, Dr. Manasi Shah carefully evaluates several clinical factors to develop a treatment plan based on the stage of the disease, tumour characteristics, molecular findings, and your overall health.

Uterine Cancer Treatment Options

There's More Than One Way to Treat Uterine Cancer

Uterine cancer treatment often combines different therapies depending on the stage of the disease, tumour biology, molecular findings, and your overall health. Each treatment is selected to achieve the best possible disease control while supporting long-term recovery.

Primary Surgery

Surgery is often the first step to remove the uterus, ovaries, and visible cancer whenever appropriate.

Chemotherapy

Anti-cancer medicines help destroy cancer cells and reduce the risk of recurrence in selected patients.

Radiation Therapy

Radiation therapy may be recommended after surgery to lower the chance of cancer returning.

Targeted Therapy

These medicines act on specific molecular changes identified within the tumour to improve treatment outcomes.

Immunotherapy

Certain advanced or recurrent uterine cancers may benefit from immunotherapy based on molecular findings.

Hormone Therapy

Hormone-blocking medicines may be suitable for selected hormone-sensitive uterine cancers and recurrent disease.

Precision Oncology

Molecular profiling helps identify treatments based on the unique biological characteristics of the tumour.

Long-Term Follow-up

Regular clinical reviews and imaging help monitor recovery and identify recurrence as early as possible.

The Specialist Guiding Your Ovarian Cancer Care

The treatment of uterine cancer requires careful interpretation of pathology findings, molecular testing, and disease stage to determine the most appropriate systemic therapy. Modern medical oncology plays an important role in supporting women before and after surgery, as well as in the treatment of recurrent or advanced disease.

Dr. Manasi Shah is a Senior Consultant – Medical Oncology & Hematology with advanced oncology training in the United States. Her expertise includes the medical management of uterine (endometrial) cancer using chemotherapy, hormone therapy, immunotherapy, targeted therapy, and precision oncology where appropriate. She has also served as a Principal Investigator in multiple international clinical trials and remains actively involved in applying evidence-based treatment strategies in clinical practice.

Senior Consultant – Medical Oncology & Hematology

Here's What to Expect

Every uterine cancer journey is different, but treatment begins with a clear understanding of your diagnosis. From your first consultation to long-term follow-up, each stage is carefully planned to support informed decisions and timely care.

Detailed Evaluation

Your journey begins with a detailed consultation, clinical examination, biopsy review, imaging studies, and blood investigations. These findings help confirm the diagnosis, determine the stage of the disease, and guide treatment planning.

Treatment Planning & Care

Based on your pathology reports, molecular findings, tumour stage, and overall health, the most appropriate treatment plan is recommended. Depending on your diagnosis, this may include surgery, chemotherapy, radiation therapy, hormone therapy, immunotherapy, or a combination of treatments.

Recovery & Long-Term Follow-up

Regular follow-up visits, clinical examinations, imaging, and ongoing assessments help monitor recovery, evaluate treatment response, detect recurrence when necessary, and support your long-term health.

Why Patients Trust Our Cancer Care

Successful uterine cancer treatment begins with an accurate diagnosis and continues through careful planning, evidence-based treatment, and structured follow-up. Every recommendation is guided by clinical findings, multidisciplinary collaboration, and ongoing assessment throughout your treatment journey.

Accurate Uterine Cancer Evaluation

Every treatment begins with a detailed review of biopsy findings, imaging, pathology, and staging to understand the disease completely.

Treatment Based on Disease Stage

Recommendations are guided by tumour stage, molecular findings, recurrence risk, and your overall health before treatment begins.

Coordinated Surgical Planning

Medical oncology care is closely coordinated with gynecologic oncologists to determine the most appropriate treatment sequence.

Structured Follow-up After Treatment

Regular clinical examinations, imaging, and ongoing reviews help monitor recovery and detect recurrence as early as possible.

Frequently Asked Questions For Uterine Cancer​

No. Postmenopausal bleeding has several possible causes, including hormonal changes or benign uterine conditions, and is not always cancer. However, any bleeding after menopause should be evaluated promptly, since ruling out uterine cancer early is essential for timely treatment if needed.

Risk factors include obesity, prolonged estrogen exposure without progesterone, late menopause, never having been pregnant, and conditions like polycystic ovary syndrome (PCOS). A family history of uterine, ovarian, or colorectal cancer, including Lynch syndrome, can also increase risk. 

Diagnosis typically involves a transvaginal ultrasound to assess the uterine lining, followed by an endometrial biopsy to confirm the presence of cancer cells. Imaging and pathology results together help determine the cancer’s grade and guide the treatment plan.

Hysterectomy is a common treatment for uterine cancer, particularly in early stages. In select younger patients who wish to preserve fertility and where the cancer is at a very early stage, hormone-based treatment may be considered; this requires careful evaluation and specialist discussion.

Estrogen-only hormone therapy without progesterone can increase uterine cancer risk in women who still have a uterus. This risk is specific to certain HRT formulations, which is why HRT use and type should always be discussed with your treating doctor.

Schedule Your Consultation Today

Whether you have recently been diagnosed, are recovering after surgery, have been advised to undergo chemotherapy or hormone therapy, or wish to seek a second opinion, consulting a Medical Oncologist can help you better understand the treatment options available. During your consultation, Dr. Manasi Shah will carefully review your biopsy and pathology reports, imaging findings, surgical records, molecular test results, and overall health before discussing the most appropriate treatment approach.